The Herbert and Jacqueline Krieger Klein Alzheimer’s Research Center focuses on advancing research to delay, prevent, and treat Alzheimer’s and related neurodegenerative diseases through innovative studies and clinical collaborations.
The Herbert and Jacqueline Krieger Klein Alzheimer’s Research Center is New Jersey’s first center dedicated solely to advancing Alzheimer’s and dementia research. Our mission is clear: to lead the way in finding solutions to prevent and treat this devastating disease. With a focus on translating groundbreaking research into real-world impact, our team is committed to improving the lives of individuals, families, and communities affected by Alzheimer’s. Through collaboration and innovation, we aim to deliver meaningful outcomes for those at risk and currently battling the disease.
The ADRD Center offers yearly a pilot grant to young investigators to support innovative studies aimed at uncovering new insights into the disease’s mechanisms and potential interventions, fostering creativity towards advancements in ADRD treatment and care.
The ADRD Center annually acknowledges an outstanding publication. This recognition celebrates excellence in basic or clinical science, spotlighting groundbreaking studies that significantly impact our understanding of ADRD or advance us closer to therapeutic breakthroughs.
The ADRD Center organizes an annual symposium, uniting top researchers, clinicians, and the ADRD community. This event fosters collaborations and encourages interdisciplinary dialogue. It aims to drive progress towards enhanced diagnosis, treatment, and prevention strategies for ADRD.
Nationally and internationally renowned experts in ADRD research are invited to present talks at our center, sharing their latest findings, insights, and perspectives. These talks offer valuable opportunities for education, inspiration, networking, and sparking new avenues of investigation within our community.
These are interactive forums where basic and clinical researchers bridge laboratory discoveries with clinical applications. In addition to providing opportunities for discussions about specific projects, these meetings foster collaborations, and accelerate the translation of scientific findings into real-world benefits for patients, advancing diagnosis and treatment.
Our Mentorship Program nurtures future leaders in the field, empowering them to make significant contributions to ADRD research and to build independent, productive research careers.
As the Director of the Herbert and Jacqueline Krieger Klein Alzheimer’s Research Center at Rutgers University, Dr. Michal Schnaider Beeri leads groundbreaking efforts to understand and address Alzheimer’s disease and dementia. With a patient-centered approach, the center is dedicated to discovering preventative treatments and interventions, focusing on the earliest signs of cognitive decline.
Dr. Beeri, also a Professor of Neurology at Robert Wood Johnson Hospital, has built a distinguished research career exploring the role of metabolic factors in brain aging and cognitive health. Her extensive work includes both epidemiological studies and clinical trials aimed at preventing and slowing Alzheimer’s disease. With over 200 peer-reviewed publications and continuous funding from the National Institutes of Health, the Alzheimer’s Association, and other foundations, Dr. Beeri’s expertise and leadership drive the center’s mission to improve the lives of individuals and families facing cognitive challenges.
Discover the groundbreaking work happening across all our Centers of Excellence. Each center contributes uniquely to advancing neuroscience research and innovation.
